Please login to the form below

Not currently logged in
Email:
Password:

Silence Therapeutics appoints Michael Khan as chief medical adviser

Will advise on translational research for its siRNA-based therapeutics

UK-based biotech Silence Therapeutics has appointed Dr Michael Khan as the company's chief medical adviser.

Dr Khan is an associate professor of medicine at the University of Warwick and a consultant physician at University Hospitals.

In his role as adviser, he will help Silence develop translational clinical research involving its siRNA-based therapeutics for the treatment of orphan diseases, and those conditions with current unmet medical need.

“I believe that Silence Therapeutics core technologies are uniquely positioned to fulfil these needs,” said Dr Khan.

Dr Khan's previous roles include head of molecular medicine at Warwick University, where he helped develop various projects in cell and molecular biology.

His work has covered cancer and diabetes, and he has written several books on the subjects. He also teaches postgraduates and undergraduates in medicine and biological sciences in these areas.

In addition, Dr Khan is a fellow of the Royal College of Physicians of London and a member of the Association of Physicians, HEART-UK and Diabetes UK.

“Michael's medical, clinical and regulatory experience will be invaluable as we look to commercialise our prospects,” said Klaus Giese, chief scientific officer of Silence.

20th September 2012

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics